Autopsy report · NCT04489381
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Ran for about 5 months before it stopped.
- 214 participants enrolled.
- Results were posted on the registry 3 years 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Romark Laboratories L.C.
- Sponsor type
- Industry
- Conditions
- Enterovirus; Rhinovirus
- Interventions
- Nitazoxanide; Placebo; Vitamin Super B-Complex
- Participants
- 214
- Sites
- 3
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.